๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study

โœ Scribed by Robert T. Dorr; Ruskin Lines; Norman Levine; Christine Brooks; Li Xiang; Victor J. Hruby; Mac E. Hadley


Book ID
116019069
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
596 KB
Volume
58
Category
Article
ISSN
0024-3205

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Phase I evaluation of vindesine in child
โœ Komp, Diane ;Vats, Tribhawan ;Shepherd, Dell A. ;Vietti, Teresa ;Hoogstraten, Ba ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 374 KB

## Abstract Twentyโ€one children (19 with leukemia) were given 34 courses of vindesine on a weekly or twiceโ€weekly schedule in escalating doses. Thirtyโ€three courses were fully or partially evaluable for response and/or toxicity. Granulocytoโ€penia was the doseโ€limiting toxicity. Transient jaw, neck,

Ex vivo ras peptide vaccination in patie
โœ Marianne K. Gjertsen; Arne Bakka; Jarle Breivik; Ingvil Saeterdal; Tobias Gedde- ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 434 KB ๐Ÿ‘ 2 views

In a pilot phase 1/11 study we have tested synthetic ras peptides used as a cancer vaccine in 5 patients with advanced pancreatic carcinoma. The treatment principle used was based on loading professional antigen-presenting cells (APCs) from peripheral blood with a synthetic ras peptide corresponding